LEP and obesity disorder: Adipocytokines such as leptin and adiponectin, which regulate and affect insulin sensitivity and signaling, are deregulated in both psoriasis and obesity, and plasma levels of adiponectin, which has anti-inflammatory action, are decreased in obesity, psoriasis, IR, and T2D [34].